Post-hoc analyses of the isradipine and nilotinib trial results
Results from major Parkinson’s clinical trials, of the blood pressure medication isradipine and the cancer treatment nilotinib, found that these drugs had no effect on the progression of the disease. Now, post-hoc analyses of the trial data have identified some interesting results that may deserve...
Learn more
Sisters fundraise and raise awareness for Cure Parkinson’s
A ground-breaking Cure Parkinson’s supported study that involved screening over 230,000 molecules has identified farnesol, a commonly found aromatic oil, as a new potential treatment of Parkinson’s.
PD Frontline
As research has expanded in the area of Parkinson’s genetics, researchers have been able to uncover a number of genes which have been linked to an increased risk of developing Parkinson’s. About 20% of Parkinson’s diagnoses are associated with genetic variations. Researchers believe that by…
Patron Paul Mayhew-Archer raises over £10k for Cure Parkinson’s and Maggie’s Cancer Centres
Arabella Slinger from London, will set off to complete this extreme and gruelling challenge in support of Parkinson’s research.
First British woman to ski Amundsen’s route to the South Pole takes on the challenge for Cure Parkinson’s
Arabella Slinger from London, will set off to complete this extreme and gruelling challenge in support of Parkinson’s research.
NECTAR 2021
The Network for European CNS Transplantation and Restoration (NECTAR) was founded over 25 years ago. Here, Dr Simon Stott presents a brief update on the events at NECTAR 2021.